Menarini Education Series in Breakthrough Cancer Pain
Module 3 – Tailoring treatment choice: Clinical pharmacokinetics
Overview
By the end of this presentation, participants should be able to:
- Recognise the fluctuating, heterogeneity nature of breakthrough cancer pain intensity and its clinical characteristics
- Describe the differences between the pharmacokinetic profiles of rapid-onset and short-acting opioids
- Effectively assess and choose an appropriate treatment based on an individual’s pain profile
Sign up to MediScene
To access this content, please register or log in.